Fate Therapeutics (FATE) FCF Margin (2012 - 2026)
Fate Therapeutics (FATE) posted FCF Margin of 2391.15% for Q1 2026, down 13.39% on a QoQ basis from 2108.77% in Q4 2025, and down 27549.0% year-over-year from N/an in Q1 2025.
Fate Therapeutics (FATE) FCF Margin (2012 - 2026) Analysis & Trends
Fate Therapeutics' FCF Margin history runs 14 years deep, the most recent figure standing at 2391.15% for Q1 2026.
- Quarterly FCF Margin fell 27549.0% year-over-year to 2391.15% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1719.98% (down 78924.0% YoY) and the FY2025 annual result came in at 1685.78%, down 78332.0% from the prior year.
- FCF Margin was 2391.15% for Q1 2026 at Fate Therapeutics, down from 2108.77% in the prior quarter.
- Across five years, FCF Margin topped out at 54.37% in Q1 2023 and bottomed at 3289.6% in Q2 2023.
- A 5-year average of 1342.37% and a median of 1365.82% in 2025 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2023 — FCF Margin sank 291225 bps — and 2024, when it surged 281073 bps.
- Fate Therapeutics' FCF Margin stood at 107.21% in 2022, then sank by 2272 bps to 2543.08% in 2023, then surged by 41 bps to 1501.24% in 2024, then tumbled by 40 bps to 2108.77% in 2025, then slipped by 13 bps to 2391.15% in 2026.
- Business Quant data shows FATE's FCF Margin at 2391.15% in Q1 2026, 2108.77% in Q4 2025, and 1365.82% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 10.45% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Fate Therapeutics | 288.82 Mn | 288.82 Mn | - | -2,391.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,391.15% |
| Dec 31, 2025 | -2,108.77% |
| Sep 30, 2025 | -1,365.82% |
| Jun 30, 2025 | -1,307.03% |
| Mar 31, 2025 | -2,115.65% |
| Dec 31, 2024 | -1,501.24% |
| Sep 30, 2024 | -953.09% |
| Jun 30, 2024 | -478.87% |
| Mar 31, 2024 | -1,733.19% |
| Dec 31, 2023 | -2,543.08% |
| Sep 30, 2023 | -1,699.28% |
| Jun 30, 2023 | -3,289.60% |
| Mar 31, 2023 | -54.37% |
| Dec 31, 2022 | -107.21% |
| Sep 30, 2022 | -425.36% |
| Jun 30, 2022 | -377.35% |
| Mar 31, 2022 | -369.23% |
| Dec 31, 2021 | -687.65% |
| Sep 30, 2021 | -136.36% |
| Jun 30, 2021 | -351.04% |